Lisata Therapeutics, Inc. (LSTA)
1.99
+0.13
(+6.99%)
USD |
NASDAQ |
Sep 09, 13:38
Lisata Therapeutics Total Liabilities (Quarterly) : 3.037M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.037M |
| March 31, 2026 | 3.387M |
| December 31, 2025 | 3.143M |
| September 30, 2025 | 4.64M |
| June 30, 2025 | 4.385M |
| March 31, 2025 | 3.879M |
| December 31, 2024 | 5.685M |
| September 30, 2024 | 4.763M |
| June 30, 2024 | 4.576M |
| March 31, 2024 | 5.497M |
| December 31, 2023 | 6.80M |
| September 30, 2023 | 5.385M |
| June 30, 2023 | 4.651M |
| March 31, 2023 | 5.623M |
| December 31, 2022 | 6.71M |
| September 30, 2022 | 6.758M |
| June 30, 2022 | 3.74M |
| March 31, 2022 | 3.222M |
| December 31, 2021 | 5.008M |
| September 30, 2021 | 4.125M |
| June 30, 2021 | 3.935M |
| March 31, 2021 | 4.593M |
| December 31, 2020 | 3.76M |
| September 30, 2020 | 4.532M |
| June 30, 2020 | 3.925M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.156M |
| December 31, 2019 | 6.60M |
| September 30, 2019 | 6.689M |
| June 30, 2019 | 6.728M |
| March 31, 2019 | 6.83M |
| December 31, 2018 | 5.619M |
| September 30, 2018 | 7.044M |
| June 30, 2018 | 8.626M |
| March 31, 2018 | 11.40M |
| December 31, 2017 | 9.313M |
| September 30, 2017 | 14.57M |
| June 30, 2017 | 18.21M |
| March 31, 2017 | 31.10M |
| December 31, 2016 | 29.66M |
| September 30, 2016 | 27.89M |
| June 30, 2016 | 31.68M |
| March 31, 2016 | 30.60M |
| December 31, 2015 | 33.92M |
| September 30, 2015 | 64.71M |
| June 30, 2015 | 62.67M |
| March 31, 2015 | 68.85M |
| December 31, 2014 | 68.20M |
| September 30, 2014 | 69.28M |
| June 30, 2014 | 56.10M |
| March 31, 2014 | 27.33M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.03M |
| Shareholders Equity (Quarterly) | 8.244M |
| Current Ratio | 3.687 |
| Net Debt Paydown Yield | 0.06% |